José Moltó

4.2k total citations
124 papers, 2.5k citations indexed

About

José Moltó is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, José Moltó has authored 124 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Infectious Diseases, 66 papers in Virology and 36 papers in Emergency Medicine. Recurrent topics in José Moltó's work include HIV/AIDS drug development and treatment (78 papers), HIV Research and Treatment (66 papers) and HIV/AIDS Research and Interventions (44 papers). José Moltó is often cited by papers focused on HIV/AIDS drug development and treatment (78 papers), HIV Research and Treatment (66 papers) and HIV/AIDS Research and Interventions (44 papers). José Moltó collaborates with scholars based in Spain, United Kingdom and United States. José Moltó's co-authors include Bonaventura Clotet, Eugènia Negredo, Núria Pérez‐Álvarez, Marta Valle, Cristina Miranda, Carmina R. Fumaz, José Ramón Santos, José A. Muñoz-Moreno, Jordi Puig and David M. Burger and has published in prestigious journals such as Blood, Gastroenterology and PLoS ONE.

In The Last Decade

José Moltó

118 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
José Moltó Spain 26 1.6k 1.1k 505 465 190 124 2.5k
Luuk Gras Netherlands 25 1.2k 0.7× 789 0.7× 346 0.7× 844 1.8× 72 0.4× 54 2.3k
Jordan E. Lake United States 31 1.8k 1.1× 926 0.8× 2.1k 4.3× 784 1.7× 121 0.6× 178 3.6k
Sandra Wagner Cardoso Brazil 23 1.0k 0.6× 435 0.4× 769 1.5× 575 1.2× 83 0.4× 117 1.9k
Ray P. Brettle United Kingdom 27 1.0k 0.6× 772 0.7× 362 0.7× 757 1.6× 73 0.4× 66 1.9k
Ellen Tedaldi United States 26 1.2k 0.7× 701 0.6× 893 1.8× 865 1.9× 49 0.3× 52 2.2k
Fiona Burns United Kingdom 28 1.8k 1.1× 517 0.5× 300 0.6× 1.4k 3.1× 59 0.3× 205 3.2k
Cynthia A. Kleeberger United States 16 1.0k 0.6× 1.3k 1.2× 348 0.7× 423 0.9× 69 0.4× 19 2.4k
Cecilia T. Costiniuk Canada 24 531 0.3× 576 0.5× 244 0.5× 445 1.0× 50 0.3× 100 1.8k
Elena Ricci Italy 36 759 0.5× 359 0.3× 780 1.5× 469 1.0× 552 2.9× 215 4.1k
Braden Hale United States 20 715 0.4× 383 0.3× 247 0.5× 698 1.5× 57 0.3× 52 1.7k

Countries citing papers authored by José Moltó

Since Specialization
Citations

This map shows the geographic impact of José Moltó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José Moltó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José Moltó more than expected).

Fields of papers citing papers by José Moltó

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José Moltó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José Moltó. The network helps show where José Moltó may publish in the future.

Co-authorship network of co-authors of José Moltó

This figure shows the co-authorship network connecting the top 25 collaborators of José Moltó. A scholar is included among the top collaborators of José Moltó based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José Moltó. José Moltó is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bailón, Lucía, José Ramón Arribas, Adrián Curran, et al.. (2025). Predictors of virological outcomes after analytical interruption of antiretroviral therapy and HTI vaccination in early treated people with HIV-1._. Communications Medicine. 6(1). 11–11.
2.
Bailón, Lucía, Àngel Rivero, Pep Coll, et al.. (2025). Strategies to Minimize Time From HIV Acquisition to ART Initiation: The Barcelona Early-cART Program. Open Forum Infectious Diseases. 12(9). ofaf545–ofaf545.
3.
Borgognone, Alessandra, Anna Prats, Ashish Sharma, et al.. (2025). Interactions between gut microbiota, plasma metabolome and brain function in the setting of a HIV cure trial. Frontiers in Cellular and Infection Microbiology. 15. 1629901–1629901.
4.
Bailón, Lucía, J Coll, José Ramón Santos, et al.. (2024). Early virological failure with cabotegravir/rilpivirine. Journal of Antimicrobial Chemotherapy. 79(5). 1193–1194. 5 indexed citations
5.
Narejos, Silvia, María José Forner, Eunate Arana‐Arri, et al.. (2024). Omicron XBB.1.16-Adapted Vaccine for COVID-19: Interim Immunogenicity and Safety Clinical Trial Results. Vaccines. 12(8). 840–840. 1 indexed citations
6.
Santos, José Ramón, Peré Domingo, Joaquín Portilla, et al.. (2023). A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes. Open Forum Infectious Diseases. 10(11). ofad542–ofad542. 2 indexed citations
7.
Llano, Anuska, Santiago Cedeño, Pep Coll, et al.. (2021). A placebo-controlled ati trial of HTI vaccines in early treated HIV infection. 29(1). 48–49. 5 indexed citations
8.
Marzolini, Catia, et al.. (2020). Drug–Drug Interactions with Antiretroviral Drugs in Pregnant Women Living with HIV: Are They Different from Non-Pregnant Individuals?. Clinical Pharmacokinetics. 59(10). 1217–1236. 9 indexed citations
9.
Santos, José Ramón, Ana Merino, Walter E. Haefeli, et al.. (2020). Ambrisentan use in a HIV-1 infected patient with end-stage renal disease and pulmonary hypertension: minimal removal by hemodialysis - a case report. BMC Nephrology. 21(1). 24–24. 2 indexed citations
10.
Leal, Lorna, Jozefien Buyze, Pieter Pannus, et al.. (2019). Therapeutic Vaccine in Chronically HIV-1-Infected Patients: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Trial with HTI-TriMix. Vaccines. 7(4). 209–209. 30 indexed citations
11.
García‐Orenes, Fuensanta, et al.. (2017). Effects of salvage logging on soil properties and vegetation recovery in a fire-affected Mediterranean forest: A two year monitoring research. The Science of The Total Environment. 586. 1057–1065. 70 indexed citations
12.
Muñoz-Moreno, José A., Anna Prats, José Moltó, et al.. (2017). Transdermal rivastigmine for HIV-associated cognitive impairment: A randomized pilot study. PLoS ONE. 12(8). e0182547–e0182547. 9 indexed citations
13.
Coll, J, José Moltó, Jaume Boix, et al.. (2015). Single oral dose of maraviroc does not prevent ex-vivo HIV infection of rectal mucosa in HIV-1 negative human volunteers. AIDS. 29(16). 2149–2154. 14 indexed citations
14.
Echeverría, Patricia, Anna Bonjoch, José Moltó, et al.. (2013). Pulse Wave Velocity as Index of Arterial Stiffness in HIV-Infected Patients Compared With a Healthy Population. JAIDS Journal of Acquired Immune Deficiency Syndromes. 65(1). 50–56. 24 indexed citations
15.
16.
Moltó, José, Marta Valle, José Ramón Santos, et al.. (2010). Efficacy and Safety of Ritonavir Dose Reduction Based on the Tipranavir Inhibitory Quotient in HIV-Infected Patients on Salvage Antiretroviral Therapy with Tipranavir/Ritonavir. AIDS Research and Human Retroviruses. 26(11). 1191–1196. 1 indexed citations
17.
Moltó, José, Elisabet Deig, Marta Valle, et al.. (2010). Effect of Nevirapine on the Steady-State Trough Concentrations of Atazanavir in HIV-Infected Patients Receiving Atazanavir/Ritonavir. Therapeutic Drug Monitoring. 32(1). 93–96. 4 indexed citations
18.
Santos, José Ramón, José Moltó, Josep M. Llibre, et al.. (2009). Unboosted Atazanavir Plus Co-formulated Lamivudine/Abacavir as a Ritonavir-Sparing Simplification Strategy in Routine Clinical Practice. HIV Clinical Trials. 10(3). 129–134. 10 indexed citations
19.
Hill, Andrew, Sharon Walmsley, Bonaventura Clotet, & José Moltó. (2006). Analysis of genotypic and phenotypic clinical cut‐off levels for ritonavir‐boosted saquinavir. HIV Medicine. 7(2). 67–74. 2 indexed citations
20.
Moltó, José, Lı́dia Ruiz, Joan Romeu, et al.. (2004). Influence of Prior Structured Treatment Interruptions on the Length of Time without Antiretroviral Treatment in Chronically HIV-Infected Subjects. AIDS Research and Human Retroviruses. 20(12). 1283–1288. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luuk Gras Breakdown of academic impact, for papers by Jordan E. Lake Breakdown of academic impact, for papers by Sandra Wagner Cardoso Breakdown of academic impact, for papers by Ray P. Brettle Breakdown of academic impact, for papers by Ellen Tedaldi Breakdown of academic impact, for papers by Fiona Burns Breakdown of academic impact, for papers by Cynthia A. Kleeberger Breakdown of academic impact, for papers by Cecilia T. Costiniuk Breakdown of academic impact, for papers by Elena Ricci Breakdown of academic impact, for papers by Braden Hale
Rankless by CCL
2026